• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma.

作者信息

Birnbaum Mathew R, Ma Michelle W, Fleisig Sarah, Packer Stuart, Amin Bijal D, Jacobson Mark, McLellan Beth N

机构信息

Department of Medicine, Division of Dermatology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York.

Department of Medicine, Division of Hematology/Oncology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York.

出版信息

JAAD Case Rep. 2017 Apr 14;3(3):208-211. doi: 10.1016/j.jdcr.2017.02.015. eCollection 2017 May.

DOI:10.1016/j.jdcr.2017.02.015
PMID:28443311
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5394200/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c5/5394200/f57539bf3688/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c5/5394200/2ec7f8f94af2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c5/5394200/f57539bf3688/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c5/5394200/2ec7f8f94af2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c5/5394200/f57539bf3688/gr2.jpg

相似文献

1
Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma.一名肺腺癌患者出现的与纳武单抗相关的皮肤结节病。
JAAD Case Rep. 2017 Apr 14;3(3):208-211. doi: 10.1016/j.jdcr.2017.02.015. eCollection 2017 May.
2
Immune checkpoint inhibitors for nonsmall cell lung cancer treatment.用于非小细胞肺癌治疗的免疫检查点抑制剂。
J Chin Med Assoc. 2017 Jan;80(1):7-14. doi: 10.1016/j.jcma.2016.08.005. Epub 2016 Sep 29.
3
Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma.免疫检查点抑制剂相关的类肉瘤样肉芽肿性炎症：在接受晚期恶性黑色素瘤治疗的患者的淋巴结细针抽吸细胞学中检测到的一种罕见不良事件。
Hum Pathol. 2019 Sep;91:69-76. doi: 10.1016/j.humpath.2019.07.001. Epub 2019 Jul 4.
4
The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry.与免疫检查点抑制剂相关的极重度免疫相关不良事件的决定因素：法国 REISAMIC 注册前瞻性研究。
Eur J Cancer. 2021 Nov;158:217-224. doi: 10.1016/j.ejca.2021.08.048. Epub 2021 Oct 7.
5
Cutaneous adverse effects of the immune checkpoint inhibitors.免疫检查点抑制剂的皮肤不良反应。
Curr Probl Cancer. 2017 Mar-Apr;41(2):125-128. doi: 10.1016/j.currproblcancer.2016.12.001. Epub 2016 Dec 14.
6
Re-immunotherapy with nivolumab plus ipilimumab in advanced non-small cell lung cancer patients previously treated with anti-programmed death-1 and/or anti-programmed death ligand-1 antibodies.纳武利尤单抗联合伊匹木单抗对既往接受过抗程序性死亡蛋白-1和/或抗程序性死亡配体-1抗体治疗的晚期非小细胞肺癌患者进行再免疫治疗。
Discov Oncol. 2023 Aug 31;14(1):163. doi: 10.1007/s12672-023-00781-5.
7
Nivolumab associated vasculopathy: A novel mechanism.纳武利尤单抗相关血管病：一种新机制。
JAAD Case Rep. 2022 Jan 29;22:8-10. doi: 10.1016/j.jdcr.2022.01.016. eCollection 2022 Apr.
8
Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review.肿瘤和免疫检查点抑制剂相关不良反应的分类特异性模式：系统评价。
Ann Oncol. 2017 Oct 1;28(10):2377-2385. doi: 10.1093/annonc/mdx286.
9
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.下一代免疫检查点抑制剂：黑色素瘤中的PD-1/PD-L1阻断
Clin Ther. 2015 Apr 1;37(4):764-82. doi: 10.1016/j.clinthera.2015.02.018. Epub 2015 Mar 29.
10
Immune checkpoint inhibitors in non-small cell lung cancer: A bird's eye view.免疫检查点抑制剂在非小细胞肺癌中的应用：鸟瞰全局。
Life Sci. 2019 Sep 15;233:116713. doi: 10.1016/j.lfs.2019.116713. Epub 2019 Aug 3.

引用本文的文献

1
Drug-Induced Sarcoid-like Reactions Associated to Targeted Therapies and Biologic Agents.与靶向治疗和生物制剂相关的药物诱导的结节病样反应。
Diagnostics (Basel). 2025 Jun 29;15(13):1658. doi: 10.3390/diagnostics15131658.
2
Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors.接受检查点抑制剂治疗的晚期实体瘤患者中的结节病样反应。
Oncologist. 2025 May 8;30(5). doi: 10.1093/oncolo/oyaf017.
3
Advance in pathogenesis of sarcoidosis: Triggers and progression.结节病发病机制的进展：触发因素与病情进展

本文引用的文献

1
Programmed Death-1 Inhibition of Phosphatidylinositol 3-Kinase/AKT/Mechanistic Target of Rapamycin Signaling Impairs Sarcoidosis CD4 T Cell Proliferation.程序性死亡-1对磷脂酰肌醇3-激酶/AKT/雷帕霉素作用机制靶点信号通路的抑制作用损害结节病CD4 T细胞增殖。
Am J Respir Cell Mol Biol. 2017 Jan;56(1):74-82. doi: 10.1165/rcmb.2016-0037OC.
2
Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy.在伊匹单抗和纳武单抗联合治疗中观察到的免疫相关性结节病。
JAAD Case Rep. 2016 Jul 14;2(3):264-8. doi: 10.1016/j.jdcr.2016.05.002. eCollection 2016 May.
3
Sarcoidosis mimicking lymphoma on FDG-PET imaging.
Heliyon. 2024 Mar 8;10(5):e27612. doi: 10.1016/j.heliyon.2024.e27612. eCollection 2024 Mar 15.
4
Immunotherapy-induced exclusively cutaneous sarcoid-like reaction.免疫治疗引起的单纯皮肤类肉瘤样反应。
BMJ Case Rep. 2023 Jul 18;16(7):e252766. doi: 10.1136/bcr-2022-252766.
5
Suspected immune checkpoint inhibitor-induced pulmonary sarcoid reaction in metastatic renal cell carcinoma.转移性肾细胞癌中疑似免疫检查点抑制剂诱导的肺部结节病反应
Clin Case Rep. 2022 Jul 11;10(7):e5960. doi: 10.1002/ccr3.5960. eCollection 2022 Jul.
6
Challenging Dermatologic Considerations Associated with Immune Checkpoint Inhibitors.免疫检查点抑制剂相关的具有挑战性的皮肤科问题。
Am J Clin Dermatol. 2022 Sep;23(5):707-717. doi: 10.1007/s40257-022-00706-y. Epub 2022 Jun 16.
7
Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review.病例报告：一名非小细胞肺癌患者中与检查点抑制相关的肝结节病样反应及文献综述
Front Oncol. 2022 Mar 10;12:824308. doi: 10.3389/fonc.2022.824308. eCollection 2022.
8
Case Report: Sarcoid-Like Reactions and Tertiary Lymphoid Structures Following Dual Checkpoint Inhibition in a Patient with Early-Stage Lung Adenocarcinoma.病例报告：早期肺腺癌患者接受双重免疫检查点抑制后出现类肉瘤样反应和三级淋巴结构。
Front Immunol. 2022 Jan 31;13:794217. doi: 10.3389/fimmu.2022.794217. eCollection 2022.
9
Drug eruptions with novel targeted therapies - immune checkpoint and EGFR inhibitors.新型靶向治疗药物的皮肤不良反应——免疫检查点抑制剂和 EGFR 抑制剂。
J Dtsch Dermatol Ges. 2021 Nov;19(11):1621-1643. doi: 10.1111/ddg.14641.
10
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer.新辅助免疫检查点抑制剂治疗非小细胞肺癌后，淋巴结免疫 flares 模拟淋巴结疾病进展。
Nat Commun. 2021 Aug 19;12(1):5045. doi: 10.1038/s41467-021-25188-0.
在氟代脱氧葡萄糖正电子发射断层扫描（FDG-PET）成像中表现类似淋巴瘤的结节病。
Radiol Case Rep. 2015 Nov 6;6(2):409. doi: 10.2484/rcr.v6i2.409. eCollection 2011.
4
Pulmonary sarcoid-like granulomatosis induced by nivolumab.纳武利尤单抗诱导的肺肉瘤样肉芽肿病。
Br J Dermatol. 2017 Apr;176(4):1060-1063. doi: 10.1111/bjd.14808. Epub 2016 Dec 19.
5
Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With Advanced Melanoma.纳武利尤单抗诱导的晚期黑色素瘤患者类肉瘤样肉芽肿反应
Chest. 2016 May;149(5):e133-6. doi: 10.1016/j.chest.2015.10.082.
6
Principles and current strategies for targeting autophagy for cancer treatment.靶向自噬治疗癌症的原则和当前策略。
Clin Cancer Res. 2011 Feb 15;17(4):654-66. doi: 10.1158/1078-0432.CCR-10-2634.
7
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells.PD-L1 调节诱导性调节 T 细胞的发育、维持和功能。
J Exp Med. 2009 Dec 21;206(13):3015-29. doi: 10.1084/jem.20090847. Epub 2009 Dec 14.
8
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.程序性死亡-1配体1与B7-1共刺激分子特异性相互作用，以抑制T细胞反应。
Immunity. 2007 Jul;27(1):111-22. doi: 10.1016/j.immuni.2007.05.016. Epub 2007 Jul 12.
9
Tissue expression of PD-L1 mediates peripheral T cell tolerance.PD-L1的组织表达介导外周T细胞耐受。
J Exp Med. 2006 Apr 17;203(4):883-95. doi: 10.1084/jem.20051776. Epub 2006 Apr 10.